Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.

MLA

Tada, Takuya, et al. “Neutralization of SARS-CoV-2 Variants by MRNA and Adenoviral Vector Vaccine-Elicited Antibodies.” Frontiers in Immunology, vol. 13, Mar. 2022, pp. 1–8. EBSCOhost, https://doi.org/10.3389/fimmu.2022.797589.

APA

Tada, T., Zhou, H., Samanovic, M. I., Dcosta, B. M., Cornelius, A., Herati, R. S., Mulligan, M. J., & Landau, N. R. (2022). Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies. Frontiers in Immunology, 13, 1–8. https://doi.org/10.3389/fimmu.2022.797589

Chicago

Tada, Takuya, Hao Zhou, Marie I. Samanovic, Belinda M. Dcosta, Amber Cornelius, Ramin S. Herati, Mark J. Mulligan, and Nathaniel R. Landau. 2022. “Neutralization of SARS-CoV-2 Variants by MRNA and Adenoviral Vector Vaccine-Elicited Antibodies.” Frontiers in Immunology 13 (March): 1–8. doi:10.3389/fimmu.2022.797589.